The court battle over Medicare’s drug price negotiation program continues to heat up ahead of a key date for deciding which drugs will be included. As of last week, there are now five organizations — three pharmaceutical companies and two trade groups — suing the federal government over the Medicare Drug Price Negotiation Program established through the Inflation Reduction Act (IRA). The program is a key pillar of the Biden administration’s health care agenda, and the White House has maintained the law is on its side when it comes to its authority to implement negotiations. Here’s what to know about the Medicare drug price negotiation legal battle: The timeline The program
Hence then, the article about what to know about the legal battle against medicare drug price negotiations was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( What to know about the legal battle against Medicare drug price negotiations )